Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Up1.00% Nasdaq Up1.29%

ACADIA Pharmaceuticals Inc. (ACAD)

-NasdaqGS
19.28 0.92(5.01%) Apr 16, 4:00PM EDT
Get the big picture on all your investments.
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Sep 30, 2013Jun 30, 2013Mar 31, 2013
Total Revenue 37   240   451   417  
Cost of Revenue -   -   -   -  
Gross Profit 37   240   451   417  
Operating Expenses
Research Development7,925  7,255  7,112  4,430  
Selling General and Administrative4,276  3,797  2,496  2,151  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (12,164) (10,812) (9,157) (6,164)
Income from Continuing Operations
Total Other Income/Expenses Net115  117  76  41  
Earnings Before Interest And Taxes(12,049)(10,695)(9,081)(6,123)
Interest Expense -   -   -   -  
Income Before Tax(12,049)(10,695)(9,081)(6,123)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(12,049)(10,695)(9,081)(6,123)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (12,049) (10,695) (9,081) (6,123)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (12,049) (10,695) (9,081) (6,123)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.